EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Prevalence of cardiometabolic multimorbidity and associated factors among adults in Türkiye

Ali Köse, Hatice Simsek, Mehmet Emin Arayici

Eastern Mediterranean Health Journal · 2026-11-10 · 32 (10) · 718-724

DOI: 10.26719/2026.32.10.718 ↗
AbstractBibliografische Angaben

Abstract

Background: Cardiometabolic diseases remain a major public health problem in Türkiye, yet national evidence on them is limited. Aim: To determine the prevalence of cardiometabolic multimorbidity and its associated factors among adults aged ≥40 years in Türkiye. Methods: We collected data on cardiometabolic multimorbidity among 9525 individuals aged ≥40 years from the 2019 Türkiye Health Survey. We analysed the data using SPSS version 24.0, using chi-square test to assess the association between categorical variables and cardiometabolic multimorbidity, and univariable and multivariable logistic regression to evaluate the strength of associations between the independent variables and cardiometabolic multimorbidity. P < 0.05 was considered statistically significant. Results: The prevalence of cardiometabolic multimorbidity was 23.4%. Being female (aOR = 1.52, 95% CI: 1.34–1.72), older age (≥70 years; aOR = 7.97, 95% CI: 6.64–9.57), having a higher body mass index (aOR = 1.09, 95% CI: 1.07–1.10), and alcohol use (aOR = 1.24, 95% CI: 1.08–1.34) were associated with increased odds of cardiometabolic multimorbidity. Physical activity (aOR = 0.71, 95% CI: 0.63–0.80) and medium (aOR = 0.76, 95% CI: 0.63–0.90) or high education levels (aOR = 0.81, 95% CI: 0.67–0.98) were protective factors. Conclusion: The high prevalence of cardiometabolic multimorbidity indicates the need for targeted strategies to prevent and better manage cardiometabolic health among this population of adults in Türkiye.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →